Biological Psychiatry Global Open Science
June 4, 2026
Petr Adámek, Veronika Rudolfová, Kristýna Malenínská et al.
Schizophrenia research has traditionally viewed visual processing abnormalities as downstream consequences of cortical dysfunction. However, the epidemiological observation that congenital cortical blindness appears to confer protection against schizophrenia, while peripheral blindness, regardless of its developmental timing, does not, indicates that visual input itself may play a more...
Biological Psychiatry Global Open Science
May 14, 2026
Anne Maj van der Velden, Jakub Vohryzek, Paulina Clara Dagnino et al.
BACKGROUND Depression is a prevalent and debilitating affective disorder characterised by the dominance and persistence of depressive rumination. Mindfulness-based cognitive therapy (MBCT) is an effective treatment for recurrent depression developed specifically to target rumination and recurrence risk by training metacognitive awareness and adaptive attention, emotion and self-regulation...
Biological Psychiatry Global Open Science
May 13, 2026
I. Austin-Zimmerman, Qiang Li, E. Johnson et al.
Background Cannabis use is associated with increased risk of psychotic disorders, but the underlying biological mechanisms remain unclear. We used genetic data to investigate the molecular pathways contributing to the association between cannabis use disorder (CUD) and psychosis. Methods We conducted a cross-disorder meta-analysis of genome-wide association studies (GWASs) on schizophrenia and...
Biological Psychiatry Global Open Science
May 1, 2026
Mario Bogdanov, Jason N Scott, Shiba M Esfand et al.
1 citation
Ketamine is increasingly used as a therapeutic option for treatment-resistant depression (TRD) due to its rapid antidepressant properties; however, the mechanisms underlying these effects remain elusive. Preclinical evidence suggests ketamine acts on neural pathways implicated in reward processing, but translational efforts have proven challenging due to a lack of paradigms allowing for...
Biological Psychiatry Global Open Science
March 1, 2026
Noam Goldway, Taly Markovits, Naomi Fine et al.
1 citation
Dissociation, an altered state of consciousness in which individuals feel detached from their body, environment, and sense of self, is a common feature of posttraumatic stress disorder (PTSD). Despite its significance, the neurocognitive processes underlying dissociation remain poorly understood, potentially limiting diagnostic precision and treatment efficacy in PTSD. To address this gap, we...
Biological Psychiatry Global Open Science
September 1, 2025
Čestmír Vejmola, Klára Šíchová, Kateřina Syrová et al.
4 citations
Psychedelics, particularly psilocin, are increasingly being studied for their mind-altering effects and potential therapeutic applications in psychiatry. Visual hallucinations, especially the illusion of motion in static images, are a hallmark of their action. Despite growing interest, the underlying mechanisms remain poorly understood, as their systematic evaluation in both humans and animals...
Biological Psychiatry Global Open Science
July 1, 2025
Benjamin Brake, Lillian Wieder, Natasha Hughes et al.
5 citations
Dissociative states, characterized by discontinuities in awareness and perception, occur in a diverse array of psychiatric disorders and contexts. These states have been experimentally modeled in the laboratory through various induction methods, but relatively little is known about the efficacy and comparability of different experimental methods. In this meta-analysis, we quantified...
Biological Psychiatry Global Open Science
July 1, 2025
Oussama Abdoun, Arnaud Poublan-Couzardot, Stéphane Offort et al.
5 citations
A significant share of meditation research relies on trait psychometric measures of mindfulness, which neglect the complex and dynamic unfolding of experiential processes entailed by meditation over time. However, there have been a few attempts to capture ongoing changes in experience during meditation. In this study, we integrated and expanded on 3 of these previous approaches to create a...
Biological Psychiatry Global Open Science
July 1, 2025
Shuang Li, Anhang Jiang, Xuefeng Ma et al.
3 citations
Internet gaming disorder (IGD) is a pervasive global mental health issue, and finding effective treatments for the disorder has been challenging. Mindfulness meditation (MM), recognized for its holistic approach that involves integrating mental and physical facets, holds promise for addressing the multifaceted nature of addiction. Nevertheless, the effect of MM on IGD and its associated neural...
Biological Psychiatry Global Open Science
July 1, 2025
Stephen A Murata, Zachary B Madaj, Colt D Capan et al.
1 citation
Treatment-resistant depression (TRD) remains a challenge, but intravenous racemic ketamine offers rapid antidepressant effects. Reliable biomarkers are needed. In this study, we examined kynurenine pathway metabolites and inflammatory cytokines as predictors of ketamine response. The Bio-K study was a multicenter, open-label trial of 74 patients with TRD who received 3 ketamine infusions over...
Biological Psychiatry Global Open Science
July 1, 2025
Yalin Sun, Meenalochani Sivasubramanian, Marija Milenkovic et al.
Adolescent-onset cannabis use confers higher risk for neuropsychiatric disorders, implicating amygdala dysfunction. However, the mechanisms that mediate Δ9-tetrahydrocannabinol (THC)-triggered neuroadaptive changes in the maturing amygdala remain unclear. Proteomic analysis of amygdala tissue from male adolescent Saimiri boliviensis nonhuman primates chronically treated with THC provided leads...
Biological Psychiatry Global Open Science
July 1, 2025
Paul S Myles, Jayashri Kulkarni, Jessica Kasza et al.
Nitrous oxide ("laughing gas") is an NMDA receptor antagonist. In the current study, our aim was to investigate the efficacy, safety, and likely optimal dose of nitrous oxide in adults with major depressive disorder (MDD). In this phase 2b randomized, double-blind trial, 81 patients with MDD were allocated on a 1:1 basis to receive nitrous oxide or oxygen/air (control); the nitrous group was...
Biological Psychiatry Global Open Science
March 1, 2025
Abigail E. Calder, Clifford Qualls, Gregor Hasler et al.
5 citations
The Hallucinogen Rating Scale (HRS) has been widely used to measure the subjective effects of psychedelics and other psychoactive substances. Its advantages include a basis in phenomenological interviews and clinical studies, straightforward items, and broad coverage of psychedelic effects. Previous studies have attempted to resolve its factor structure but were limited by small samples of...
Biological Psychiatry Global Open Science
March 1, 2025
Noga Aviad, Oz Moskovich, Ophir Orenstein et al.
There has been rapid growth of neuroelectrophysiological studies that aspire to uncover the "black box" of mindfulness and meditation. Reliance on traditional data analysis methods hinders understanding of the complex, nonlinear, multidimensional, and systemic nature of the functional neuroelectrophysiology of meditation states. Thus, to reveal the complex systemic neuroelectrophysiology of...
Biological Psychiatry Global Open Science
March 1, 2025
Lara M.c. Puhlmann, Pascal Vrtička, Roman Linz et al.
In this study, we investigated whether mindfulness- and meditation-based mental training that improves stress regulation can upregulate BDNF (brain-derived neurotrophic factor), an important promoter of hippocampal neuroplasticity, and examined cortisol reduction as a mediating pathway. In a randomized clinical trial, 332 healthy adults were randomly assigned to one of the 3 training cohorts or...
Biological Psychiatry Global Open Science
2025
Perla Kaliman, María Jesús Álvarez-López, Asrar Lehodey et al.
Shorter telomeres are associated with increased risk of cognitive decline and age-related diseases. Developing interventions to promote healthy aging by preserving telomere integrity is of paramount importance. Here, we investigated the effect of an 18-month meditation intervention on telomere length (TL) measures in older people without cognitive impairment. A total of 137 adults age ≥65 years...
Biological Psychiatry Global Open Science
November 1, 2024
Dhakshin Ramanathan, Jason Nan, Gillian Grennan et al.
10 citations
Interoceptive attention to internal sensory signals, such as the breath, is fundamental to mindfulness. However, interoceptive attention can be difficult to study, with many studies relying on subjective and retrospective measures. Response consistency is an established method for evaluating variability of attention on exteroceptive attention tasks, but it has rarely been applied to...
Biological Psychiatry Global Open Science
November 1, 2024
Isaac N Treves, Hilary A Marusak, Alexandra Decker et al.
7 citations
Trait mindfulness-the tendency to attend to present-moment experiences without judgment-is negatively correlated with adolescent anxiety and depression. Understanding the neural mechanisms that underlie trait mindfulness may inform the neural basis of psychiatric disorders. However, few studies have identified brain connectivity states that are correlated with trait mindfulness in adolescence,...
Biological Psychiatry Global Open Science
November 1, 2024
Sébastien Czajko, Jelle Zorn, Loïc Daumail et al.
5 citations
Short mindfulness-based interventions have gained traction in research due to their positive impact on well-being, cognition, and clinical symptoms across various settings. However, these short-term trainings are viewed as preliminary steps within a more extensive transformative path, presumably leading to long-lasting trait changes. Despite this, little is still known about the brain...
Biological Psychiatry Global Open Science
October 17, 2024
Nicco Reggente, Christian Kothe, Tracy Brandmeyer et al.
15 citations
Meditation practices have demonstrated numerous psychological and physiological benefits, but capturing the neural correlates of varying meditative depths remains challenging. In this study, we aimed to decode self-reported time-varying meditative depth in expert practitioners using electroencephalography (EEG). Expert Vipassana meditators ( n = 34) participated in 2 separate sessions....
Biological Psychiatry Global Open Science
July 1, 2024
Julia Aepfelbacher, Benjamin Panny, Rebecca B Price
13 citations
Ketamine, an NMDA receptor antagonist, provides rapid antidepressant effects. Although much research has focused on neural and molecular mechanisms of action, it is critical to also consider psychological mechanisms that may contribute to its therapeutic efficacy. The construct of an awe-inducing experience, which is a well-validated psychological phenomenon tied to emotional well-being, had...
Biological Psychiatry Global Open Science
2024
Victorita E. Ivan, David P Tomàs-Cuesta, Ingrid M. Esteves et al.
7 citations
The ability of psychedelic compounds to profoundly alter mental function has been long known, but the underlying changes in cellular-level information encoding remain poorly understood. We used two-photon microscopy to record from the retrosplenial cortex in head-fixed mice running on a treadmill before and after injection of the nonclassic psychedelic ibogaine (40 mg/kg intraperitoneally). We...
Biological Psychiatry Global Open Science
October 1, 2023
Ben Julian A Palanca, Charles R Conway, Thomas Zeffiro et al.
Nitrous oxide holds promise in the treatment of major depressive disorder. Its psychotropic effects and NMDA receptor antagonism have led to comparisons with ketamine. Despite longstanding use, persistent effects of nitrous oxide on the brain have not been characterized. Sixteen healthy volunteers were recruited in a double-blind crossover study. In randomized order, individuals underwent a...